The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Vascular Endothelial Growth Factor Modulates the Transendothelial Migration of MDA-MB-231 Breast Cancer Cells through Regulation of Brain Microvascular Endothelial Cell Permeability
Open accessAbstract
Vascular endothelial growth factor (VEGF), also known as vascular permeability factor (VPF), has been shown to increase potently the permeability of endothelium and is highly expressed in breast cancer cells. In this study, we investigated the role of VEGF/VPF in breast cancer metastasis to the brain. Very little is known about the role of endothelial integrity in the extravasation of breast cancer cells to the brain. We hypothesized that VEGF/VPF, having potent vascular permeability activity, may support tumor cell penetration across blood vessels by inducing vascular leakage. To examine this role of VEGF/VPF, we used a Transwell culture system of the human brain microvascular endothelial cell (HBMEC) monolayer as an in vitro model for the blood vessels. We observed that VEGF/VPF significantly increased the penetration of the highly metastatic MDA-MB-231 breast cancer cells across the HBMEC monolayer. We found that the increased transendothelial migration (TM) of MDA-MB-231 cells resulted from the increased adhesion of tumor cells onto the HBMEC monolayer. These effects (TM and adhesion of tumor cells) were inhibited by the pre-treatment of the HBMEC monolayer with the VEGF/VPF receptor (KDR/Flk-1) inhibitor, SU-1498, and the calcium chelator 1,2-bis(O-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (acetoxymethyl)ester. These treatments of the HBMEC monolayer also inhibited VEGF/VPF-induced permeability and the cytoskeletal rearrangement of the monolayer. These data suggest that VEGF/VPF can modulate the TM of tumor cells by regulating the integrity of the HBMEC monolayer. Taken together, these findings indicate that VEGF/VPF might contribute to breast cancer metastasis by enhancing the TM of tumor cells through the down-regulation of endothelial integrity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605
Research works printed but not linked: 49
- Orr, 2000, J. Pathol., 190, 310, 10.1002/(SICI)1096-9896(200002)190:3<310::AID-PATH525>3.0.CO;2-P · doi:10.1002/(sici)1096-9896(200002)190:3<310::aid-path525>3.0.co;2-p
- Nicolson, 1994, Oncogenesis, 5, 451, 10.1615/CritRevOncog.v5.i5.20 · DOI
- Nicolson, 1988, Cancer Metastasis Rev., 7, 143, 10.1007/BF00046483 · DOI · Paper page
- Akiyama, 1995, Cancer Metastasis Rev., 14, 173, 10.1007/BF00690290 · DOI · Paper page
- Thurston, 1999, Science, 286, 2511, 10.1126/science.286.5449.2511 · DOI · Paper page
- Thurston, 2000, Nat. Med., 6, 460, 10.1038/74725 · DOI · Paper page
- Olesen, 1986, Brain Res., 368, 24, 10.1016/0006-8993(86)91038-3 · DOI
- Tanno, 1992, J. Neurotrauma, 9, 335, 10.1089/neu.1992.9.335 · DOI
- Ikeda, 1995, J. Biol. Chem., 270, 19761, 10.1074/jbc.270.34.19761 · DOI · Paper page
- Gleadle, 1995, Am. J. Physiol., 268, C1362, 10.1152/ajpcell.1995.268.6.C1362 · DOI · Paper page
- Neufeld, 1999, FASEB J., 13, 9, 10.1096/fasebj.13.1.9 · DOI · Paper page
- Ferrara, 1997, Endocr. Rev., 18, 4, 10.1210/edrv.18.1.0287 · DOI · Paper page
- Brekken, 2000, Cancer Res., 60, 5117
- Senger, 1986, Cancer Res., 46, 5629
- Brown, 1995, Hum. Pathol., 26, 86, 10.1016/0046-8177(95)90119-1 · DOI · Paper page
- Berkman, 1993, J. Clin. Invest., 91, 153, 10.1172/JCI116165 · DOI · Paper page
- Boocock, 1995, J. Natl. Cancer Inst., 87, 506, 10.1093/jnci/87.7.506 · DOI · Paper page
- Bachelder, 2001, Cancer Res., 61, 5736
- Lee, 2002, J. Biol. Chem., 277, 10445, 10.1074/jbc.M107348200 · DOI · Paper page
- Gospodarowicz, 1986, J. Cell. Physiol., 127, 121, 10.1002/jcp.1041270116 · DOI · Paper page
- De Jong, 1998, J. Pathol., 184, 53, 10.1002/(SICI)1096-9896(199801)184:1<53::AID-PATH6>3.0.CO;2-7 · DOI · Paper page
- Friesel, 1995, FASEB J., 9, 919, 10.1096/fasebj.9.10.7542215 · DOI · Paper page
- Kramer, 1980, Int. J. Cancer., 26, 639, 10.1002/ijc.2910260516 · DOI · Paper page
- Dejana, 1999, Exp. Cell Res., 252, 13, 10.1006/excr.1999.4601 · DOI · Paper page
- Honn, 1989, FASEB J., 3, 2285, 10.1096/fasebj.3.11.2673900 · DOI
- Kusama, 1995, Int. J. Cancer., 63, 112, 10.1002/ijc.2910630120 · doi:10.1002/ijc.2910630120
- Lewalle, 1998, Clin. Exp. Metastasis, 16, 21, 10.1023/A:1006555800862 · doi:10.1023/a:1006555800862
- Curry, 1992, FASEB J., 6, 2456, 10.1096/fasebj.6.7.1563597 · doi:10.1096/fasebj.6.7.1563597
- Morel, 1990, Inflammation, 14, 571, 10.1007/BF00914277 · DOI
- van Nieuw Amerongen, 1998, Circ. Res., 83, 1115, 10.1161/01.RES.83.11.1115 · DOI · Paper page
- Bates, 1997, Am. J. Physiol., 273, H687, 10.1152/ajpcell.1997.273.2.C687 · DOI
- Kevil, 1998, J. Biol. Chem., 273, 15099, 10.1074/jbc.273.24.15099 · DOI · Paper page
- Huang, 1993, J. Cell Biol., 120, 1371, 10.1083/jcb.120.6.1371 · DOI · Paper page
- Ziegelstein, 1994, Circulation, 90, 1899, 10.1161/01.CIR.90.4.1899 · DOI
- Pfau, 1995, J. Cell Biol., 128, 969, 10.1083/jcb.128.5.969 · DOI
- Etienne-Manneville, 2000, J. Immunol., 165, 3375, 10.4049/jimmunol.165.6.3375 · DOI · Paper page
- Kim, 2001, J. Biol. Chem., 276, 7614, 10.1074/jbc.M009705200 · DOI · Paper page
- Kim, 2001, Circ. Res., 89, 477, 10.1161/hh1801.097034 · DOI · Paper page
- Brodt, 1997, Int. J. Cancer., 71, 612, 10.1002/(SICI)1097-0215(19970516)71:4<612::AID-IJC17>3.0.CO;2-D · DOI
- Laferriere, 2001, J. Biol. Chem., 276, 33762, 10.1074/jbc.M008564200 · doi:10.1074/jbc.m008564200
- Nagayasu, 1998, Br. J. Cancer., 77, 1371, 10.1038/bjc.1998.229 · DOI
- Shibata, 2000, Tumour Biol., 21, 299, 10.1159/000030135 · doi:10.1159/000030135
- Gehlsen, 1988, J. Cell Biol., 106, 925, 10.1083/jcb.106.3.925 · DOI · Paper page
- Yi, 2001, Proc. Natl. Acad. Sci. U. S. A., 98, 620, 10.1073/pnas.98.2.620 · DOI · Paper page
- Fujita, 1992, Jpn. J. Cancer Res., 83, 1317, 10.1111/j.1349-7006.1992.tb02764.x · DOI
- Miralem, 2001, Oncogene, 20, 5511, 10.1038/sj.onc.1204753 · DOI
- Price, 2001, Cell Growth Differ., 12, 129
- Gerber, 2002, Nature, 417, 954, 10.1038/nature00821 · DOI · Paper page
- Melnyk, 1996, Cancer Res., 56, 921
Cited by
Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets
Liang, Y., Zhang, H., Song, X., & Yang, Q. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.012 · Cited by 992
Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function
Zervantonakis, I. K., Hughes-Alford, S. K., Charest, J. L., Condeelis, J. S., Gertler, F. B., & Kamm, R. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210182109 · Cited by 872
“The measured permeability increases for the tumor and epithelial cells may be facilitated via secretion of angiogenic factors such as VEGF (44).”
BackgroundInfluentialTominaga, N., Kosaka, N., Ono, M., Katsuda, T., Yoshioka, Y., Tamura, K., Lötvall, J., Nakagama, H., & Ochiya, T. (2015) · Nature Communications · doi:10.1038/ncomms7716 · Cited by 724
The Blood-Brain Barrier in Brain Homeostasis and Neurological Diseases
Weiss, N., Miller, F., Cazaubon, S., & Couraud, P.-O. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.10.022 · Cited by 731
Heme oxygenase–1, oxidation, inflammation, and atherosclerosis
Araujo, J. A., Zhang, M., & Yin, F. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00119 · Cited by 443
Breast Cancer Metastasis to the Central Nervous System
Weil, R. J., Palmieri, D. C., Bronder, J. L., Stark, A. M., & Steeg, P. S. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61180-7 · Cited by 434
Hypoxia-driven selection of the metastatic phenotype
Sullivan, R., & Graham, C. H. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9062-2 · Cited by 410
Complement Component 3 adapts the cerebrospinal fluid for leptomeningeal metastasis.
Boire, A., Zou, Y., Shieh, J., Macalinao, D. G., Pentsova, E., & Massagué, J. (2017) · Cell · doi:10.1016/j.cell.2017.02.025 · Cited by 366
Lu, S., Ahn, D., Johnson, G., Law, M., Zagzag, D., & Grossman, R. I. (2004) · Radiology · doi:10.1148/radiol.2321030653 · Cited by 324
Breast cancer brain metastases: biology and new clinical perspectives
Witzel, I., Oliveira-Ferrer, L., Pantel, K., Müller, V., & Wikman, H. (2016) · Breast Cancer Research · doi:10.1186/s13058-015-0665-1 · Cited by 300
Passing the Vascular Barrier: Endothelial Signaling Processes Controlling Extravasation
Wettschureck, N., Strilic, B., & Offermanns, S. (2019) · Physiological Reviews · doi:10.1152/physrev.00037.2018 · Cited by 286
Bosch, A., Eroles, P., Zaragoza, R., Viña, J. R., & Lluch, A. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.12.002 · Cited by 283
VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2
Zhao, D., Pan, C., Sun, J., Gilbert, C., Drews-Elger, K., Azzam, D. J., Picon-Ruiz, M., Kim, M., Ullmer, W., El-Ashry, D., et al. (2015) · Oncogene · doi:10.1038/onc.2014.257 · Cited by 267
Lee, T.-H., Seng, S., Sekine, M., Hinton, C., Fu, Y., Avraham, H. K., & Avraham, S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040186 · Cited by 265
Self-citationGerstner, E. R., & Fine, R. L. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.0677 · Cited by 265
Stepping out of the flow: capillary extravasation in cancer metastasis
Miles, F. L., Pruitt, F. L., van Golen, K. L., & Cooper, C. R. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9098-2 · Cited by 262
Phosphoinositide 3‐kinases in cell migration
Cain, R. J., & Ridley, A. J. (2009) · Biology of the Cell · doi:10.1042/bc20080079 · Cited by 259
Endothelial Cells in the Tumor Microenvironment
Sobierajska, K., Ciszewski, W. M., Sacewicz-Hofman, I., & Niewiarowska, J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-37184-5_6 · Cited by 179
Live-Cell Imaging of Invasion and Intravasation in an Artificial Microvessel Platform
Wong, A. D., & Searson, P. C. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1042 · Cited by 132
A microfluidic platform for quantitative analysis of cancer angiogenesis and intravasation
Lee, H., Park, W., Ryu, H., & Jeon, N. L. (2014) · Biomicrofluidics · doi:10.1063/1.4894595 · Cited by 130
Metadata
- Authors
- Lee, T.-H., Avraham, H. K., Jiang, S., & Avraham, S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-02
- Volume
- 278
- Issue
- 7
- Pages
- 5277-5284
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1995042765
- Cited by
- 214
- References
- 1
- FWCI
- 3.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6452 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.